Joshi Gagan, Wilens Timothy
Pervasive Developmental Disorders Program, Clinical and Research Programs in Pediatric Psychopharmacology, Massachusetts General Hospital, Harvard Medical School, 32 Fruit Street, Boston, MA 02114, USA.
Child Adolesc Psychiatr Clin N Am. 2009 Apr;18(2):291-319, vii-viii. doi: 10.1016/j.chc.2008.12.005.
The growing literature shows the pervasiveness and importance of comorbidity in youth with bipolar disorder (BPD). For instance, up to 90% of youth with BPD have been described to manifest comorbidity with attention-deficit hyperactivity disorder. Multiple anxiety, substance use, and disruptive behavior disorders are the other most commonly reported comorbidities with BPD. Moreover, important recent data highlight the importance of obsessive-compulsive and pervasive developmental illness in the context of BPD. Data suggest that not only special developmental relationships are operant in the context of comorbidity but also that the presence of comorbid disorders with BPD results in a more severe clinical condition. Moreover, the presence of comorbidity has therapeutic implications for the treatment response for both BPD and the associated comorbid disorder. Future longitudinal studies to address the relationship and the impact of comorbid disorders on course and therapeutic response over time are required in youth with BPD.
越来越多的文献表明,共病在双相情感障碍(BPD)青少年中普遍存在且十分重要。例如,高达90%的BPD青少年被描述为患有注意力缺陷多动障碍共病。多种焦虑症、物质使用障碍和破坏性行为障碍是其他最常报告的与BPD共病的疾病。此外,最近的重要数据凸显了在BPD背景下强迫症和广泛性发育障碍的重要性。数据表明,不仅特殊的发育关系在共病情况下起作用,而且BPD共病障碍的存在会导致更严重的临床状况。此外,共病的存在对BPD和相关共病障碍的治疗反应具有治疗意义。未来需要针对BPD青少年进行纵向研究,以探讨共病障碍之间的关系及其对病程和治疗反应随时间的影响。